Glial cells are being increasingly implicated in mechanisms underlying pathological pain, and recent studies suggest glial gap junctions involving astrocytes may contribute. The aim of this study was to examine the effect of a gap junction blocker, carbenoxolone (CBX), on medullary dorsal horn (MDH) nociceptive neuronal properties and facial mechanical nociceptive behavior in a rat trigeminal neuropathic pain model involving partial transection of the infraorbital nerve (p-IONX). p-IONX produced facial mechanical hypersensitivity reflected in significantly reduced head withdrawal thresholds that lasted for more than 3 weeks. p-IONX also produced central sensitization in MDH nociceptive neurons that was reflected in significantly increased receptive field size, reduction of mechanical activation threshold, and increases in noxious stimulation-evoked responses. Intrathecal CBX treatment significantly attenuated the p-IONX-induced mechanical hypersensitivity and the MDH central sensitization parameters, compared to intrathecal vehicle treatment. These results provide the first documentation that gap junctions may be critically involved in orofacial neuropathic pain mechanisms. Ó
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Introduction
Central sensitization reflects an increased excitability of nociceptive neurons in central nociceptive pathways after inflammation or nerve injury, and is implicated in the development and maintenance of chronic pain [19, 23, 37, 49] . In the trigeminal system, trigeminal subnucleus caudalis shares many morphological and functional similarities with the spinal dorsal horn and is often termed the medullary dorsal horn (MDH). We have previously shown that central sensitization in functionally identified nociceptive MDH neurons occurs in acute and chronic orofacial inflammatory pain models [8-10,12,42,52] as well as in chronic neuropathic pain models [4,19,29,37] in which the nerve-injured animals show nociceptive behavior accompanying the MDH central sensitization.
There is increasing evidence for the involvement of glial cells, specifically microglia and astrocytes, in the genesis and maintenance of various pathological pain states. Astrocytes and microglia are activated in response to a variety of manipulations that generate persistent nociceptive behavior in animal models of pathological pain [19, 21, 22, 24, 29, 43, 44, 48] . Neurotransmitters such as glutamate and adenosine triphosphate (ATP) released from neurons also bind to glial receptors or pass through transporters/ channels to activate various downstream signaling systems within glial cells and to induce the release of proinflammatory cytokines and other chemical mediators that act on neighboring glial cells or neurons to facilitate nociceptive signal transmission [19] [20] [21] [22] 25, 43, 46, 47] . Glial cell inhibitors can suppress the nociceptive behavior and central sensitization occurring in animal models of pathological pain states [7, 11, 17, 19, 20, 25, 26, 37, 42, 46, 47] .
The glial involvement in these pain states may involve gap junctions, which are specialized intercellular transmembrane channels that connect the cytoplasm of adjacent cells, ( 
